Understanding poultry vaccine delivery systems in low-resource settings: a systems analysis from Uganda
This study employs a systems analysis of Uganda's poultry vaccine delivery to reveal that underperformance is driven by interconnected structural bottlenecks and reinforcing feedback loops rather than mere access issues, highlighting the need to strengthen governance and key leverage points like cold-chain integrity and post-market surveillance to improve disease prevention and reduce antimicrobial reliance.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
In the crowded, dusty markets of rural Uganda, a small flock of chickens represents a family's entire financial security. When a disease strikes, it can wipe out that livelihood overnight. For decades, scientists and policymakers have known that vaccination is the most reliable shield against these outbreaks, particularly for viral diseases like Newcastle disease, which has no cure other than supportive care. Vaccines work by training the bird's immune system to fight off infection before it starts, a process that also reduces the need for farmers to use antibiotics as a preventative measure. This reduction in antibiotic use is critical for global health, as the overuse of these drugs in animals is a major driver of antimicrobial resistance, a growing crisis where medicines stop working on humans and animals alike. Yet, despite the availability of vaccines and the clear logic of their use, vaccination rates in many low-resource settings remain frustratingly low and inconsistent. The question has long been why: is it because the vaccines do not work, because farmers do not want them, or because the system meant to get the vaccines from the factory to the farm is broken?
A team of researchers set out to answer this by looking at the entire journey of a poultry vaccine in Uganda, treating the delivery system not as a simple line of boxes and trucks, but as a complex web of people, rules, and incentives. They conducted a deep dive into how vaccines move from international manufacturers, through importers and distributors, down to drug shops, and finally into the hands of farmers. By interviewing thirty-seven key people involved in this chain—from government regulators and importers to the shopkeepers who sell the vaccines and the veterinarians who administer them—they mapped out the hidden connections that keep the system functioning or failing. Their goal was to understand the structural reasons why a vaccine might arrive at a farm in a state that renders it useless, even if it was perfect when it left the factory.
The researchers found that the problem is not a lack of vaccines or a lack of willing farmers. Instead, the system is organized in a way that guarantees failure. The delivery chain is heavily dependent on imports, with most vaccines arriving at the airport in Kampala and then moving through a private network of distributors. While the government regulates the entry of these vaccines, its oversight effectively stops once the products leave the port. As the vaccines move further away from the capital and toward rural farms, the system becomes fragmented. Responsibility for keeping the vaccines cold, handling them correctly, and ensuring they are used properly shifts to actors who often lack the resources, training, or authority to do so. The study identified four main bottlenecks that trap the system in a cycle of poor performance. First, the "cold chain"—the unbroken series of refrigerated storage and transport needed to keep vaccines potent—is fragile. Unreliable electricity and a lack of refrigeration units mean that vaccines often sit in the heat, losing their ability to work before they ever reach a bird.
Second, there is a severe lack of monitoring after the vaccines are sold. Once a vaccine leaves the importer's warehouse, there is little systematic way to track if it is being stored correctly or if it is actually working on the farm. If a batch of vaccines fails, the regulators often do not know until it is too late, and the feedback loop that should correct the problem is broken. Third, the market is driven by price rather than quality. Because farmers and shopkeepers are often struggling with tight budgets, they tend to choose the cheapest option available. This pressure forces distributors and retailers to cut corners, skipping investments in proper storage or reliable transport to keep costs down. Finally, the people at the very end of the chain, the shopkeepers and farmers themselves, often lack the technical knowledge to handle the vaccines correctly. They may reconstitute a vaccine and sell it over several days, or transport it in a hot vehicle, unknowingly destroying its effectiveness.
These four problems do not exist in isolation; they feed into each other in a vicious cycle. When vaccines fail because they were stored in the heat, farmers lose trust in them. When trust drops, demand drops. When demand drops, retailers and distributors have less money and less incentive to invest in better storage or training. This leads to even more failures, which further erodes trust, creating a self-reinforcing loop that keeps the system stuck in a state of underperformance. The researchers also found that this broken system hurts the poorest farmers the most. Large, industrial farms with their own refrigeration trucks and direct supply lines can protect their flocks, but small-scale farmers in remote areas are left to rely on a chaotic, unregulated market where the risk of receiving a spoiled vaccine is highest.
The study suggests that simply making more vaccines available or telling farmers to vaccinate their birds will not fix the problem. The solution lies in fixing the specific points in the system where the cycle can be broken. The researchers identified four critical areas where intervention could have the biggest impact: ensuring the cold chain remains intact all the way to the farm, building a system to monitor vaccine performance after they are sold, changing how vaccines are bought to prioritize quality over the lowest price, and training the people who handle the vaccines at the last mile. By strengthening these specific links, the entire system could shift from a cycle of failure to one of reliability. This approach does not just help the chickens; it offers a path to reduce the reliance on antibiotics, protecting the health of both animals and the people who depend on them. The paper concludes that in low-resource settings, the success of a vaccine depends less on the science of the shot itself and more on the quality of the system that delivers it. Without fixing the delivery system, even the best vaccine will fail to protect the flock.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.